These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 24246248)

  • 1. Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.
    Cui C; Wang S; Myneni VD; Hitomi K; Kaartinen MT
    Bone; 2014 Feb; 59():127-38. PubMed ID: 24246248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin (5-HT) inhibits Factor XIII-A-mediated plasma fibronectin matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation.
    Cui C; Kaartinen MT
    Bone; 2015 Mar; 72():43-52. PubMed ID: 25460579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
    Al-Jallad HF; Nakano Y; Chen JL; McMillan E; Lefebvre C; Kaartinen MT
    Matrix Biol; 2006 Apr; 25(3):135-48. PubMed ID: 16469487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XIIIA transglutaminase expression and secretion by osteoblasts is regulated by extracellular matrix collagen and the MAP kinase signaling pathway.
    Piercy-Kotb SA; Mousa A; Al-Jallad HF; Myneni VD; Chicatun F; Nazhat SN; Kaartinen MT
    J Cell Physiol; 2012 Jul; 227(7):2936-46. PubMed ID: 21959563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.
    Mousa A; Cui C; Song A; Myneni VD; Sun H; Li JJ; Murshed M; Melino G; Kaartinen MT
    Cell Death Differ; 2017 May; 24(5):844-854. PubMed ID: 28387755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.
    Al-Jallad HF; Myneni VD; Piercy-Kotb SA; Chabot N; Mulani A; Keillor JW; Kaartinen MT
    PLoS One; 2011 Jan; 6(1):e15893. PubMed ID: 21283799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.
    Forsprecher J; Wang Z; Nelea V; Kaartinen MT
    Amino Acids; 2009 Apr; 36(4):747-53. PubMed ID: 18604470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detyrosinated Glu-tubulin is a substrate for cellular Factor XIIIA transglutaminase in differentiating osteoblasts.
    Wang S; Cui C; Hitomi K; Kaartinen MT
    Amino Acids; 2014 Jun; 46(6):1513-26. PubMed ID: 24643364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and localization of plasma transglutaminase factor XIIIA in bone.
    Nakano Y; Al-Jallad HF; Mousa A; Kaartinen MT
    J Histochem Cytochem; 2007 Jul; 55(7):675-85. PubMed ID: 17341477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.
    Nakano Y; Addison WN; Kaartinen MT
    Bone; 2007 Oct; 41(4):549-61. PubMed ID: 17669706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
    Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
    J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts.
    Wang S; Kaartinen MT
    J Histochem Cytochem; 2015 Nov; 63(11):829-41. PubMed ID: 26231113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2.
    Nelea V; Nakano Y; Kaartinen MT
    Protein J; 2008 Jun; 27(4):223-33. PubMed ID: 18330684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus fibronectin-binding protein serves as a substrate for coagulation factor XIIIa: evidence for factor XIIIa-catalyzed covalent cross-linking to fibronectin and fibrin.
    Matsuka YV; Anderson ET; Milner-Fish T; Ooi P; Baker S
    Biochemistry; 2003 Dec; 42(49):14643-52. PubMed ID: 14661977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures.
    Nakano Y; Forsprecher J; Kaartinen MT
    J Cell Physiol; 2010 Apr; 223(1):260-9. PubMed ID: 20049897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating fibronectin affects bone matrix, whereas osteoblast fibronectin modulates osteoblast function.
    Bentmann A; Kawelke N; Moss D; Zentgraf H; Bala Y; Berger I; Gasser JA; Nakchbandi IA
    J Bone Miner Res; 2010 Apr; 25(4):706-15. PubMed ID: 19821765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures.
    Hong HH; Pischon N; Santana RB; Palamakumbura AH; Chase HB; Gantz D; Guo Y; Uzel MI; Ma D; Trackman PC
    J Cell Physiol; 2004 Jul; 200(1):53-62. PubMed ID: 15137057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
    Yuan L; Siegel M; Choi K; Khosla C; Miller CR; Jackson EN; Piwnica-Worms D; Rich KM
    Oncogene; 2007 Apr; 26(18):2563-73. PubMed ID: 17099729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transglutaminase factor XIIIA in the cartilage of developing avian long bones.
    Nurminskaya MV; Recheis B; Nimpf J; Magee C; Linsenmayer TF
    Dev Dyn; 2002 Jan; 223(1):24-32. PubMed ID: 11803567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine residues of IGF-I are substrates for transglutaminases and modulate downstream IGF-I signalling.
    Sivaramakrishnan M; Croll TI; Gupta R; Stupar D; Van Lonkhuyzen DR; Upton Z; Shooter GK
    Biochim Biophys Acta; 2013 Dec; 1833(12):3176-3185. PubMed ID: 24036101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.